Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database

Am J Hematol. 2015 Apr;90(4):E73-4. doi: 10.1002/ajh.23932. Epub 2015 Feb 2.

Authors

Morten O Holmström¹, Peter Gimsing, Niels Abildgaard, Niels F Andersen, Carsten Helleberg, Niels Aage T Clausen, Tobias W Klausen, Mikael Frederiksen, Dan L Kristensen, Herdis Larsen, Per T Pedersen, Kristian Thidemann Andersen, Robert Schou Pedersen, Bo Amdi Jensen, Henrik Gregersen, Annette J Vangsted

Affiliation

¹ Department of Hematology, Roskilde Hospital, Roskilde, 4000, Denmark.

PMID: 25561348
DOI: 10.1002/ajh.23932

No abstract available

Publication types

Letter

MeSH terms

Aged
Antineoplastic Agents / administration & dosage*
Cause of Death
Databases, Factual
Denmark
Hematopoietic Stem Cell Transplantation*
Humans
Logistic Models
Multiple Myeloma / mortality*
Multiple Myeloma / therapy*
Registries
Survival Analysis

Substances

Antineoplastic Agents